Cargando…

Structure and Function of the Hef Glycoprotein of Influenza C Virus

Soon after the first isolation of an influenza C virus from a patient, it became obvious that this virus differs from other myxoviruses in several aspects. Pronounced differences have been observed in the interactions between the virus and cell surfaces, suggesting that influenza C virus attaches to...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrler, Georg, Klenk, Hans-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press Inc. Published by Elsevier Inc. 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131673/
https://www.ncbi.nlm.nih.gov/pubmed/1957719
http://dx.doi.org/10.1016/S0065-3527(08)60280-8
_version_ 1783517292172148736
author Herrler, Georg
Klenk, Hans-Dieter
author_facet Herrler, Georg
Klenk, Hans-Dieter
author_sort Herrler, Georg
collection PubMed
description Soon after the first isolation of an influenza C virus from a patient, it became obvious that this virus differs from other myxoviruses in several aspects. Pronounced differences have been observed in the interactions between the virus and cell surfaces, suggesting that influenza C virus attaches to the receptors different from those recognized by other myxoviruses. While influenza A and B viruses agglutinate erythrocytes from many species, including humans, the spectrum of erythrocytes agglutinated by influenza C virus is much more restricted. Erythrocytes from rats, mice, and adult chickens are suitable for hemagglutination and hemadsorption tests; cells from other species, however, react not at all or only poorly with influenza C virus. Differences are also observed so far as hemagglutination inhibitors are concerned. A variety of glycoproteins have been shown to prevent influenza A and B viruses from agglutinating erythrocytes. In the case of influenza C virus, rat serum was for a long time the only known hemagglutination inhibitor. A difference in the receptors for influenza C virus and other myxo-viruses was also suggested by studies on the receptor-destroying enzyme. The ability of influenza C virus to inactivate its own receptors was reported soon after the first isolation of this virus from a patient. However, the influenza C enzyme did not affect the receptors of other myxoviruses and, conversely, the receptor-destroying enzyme of either of the latter viruses was unable to inactivate the receptors for influenza C virus on erythrocytes. While the enzyme of influenza A and B virus was characterized as a neuraminidase in the 1950s, even with refined methodology no such activity was detectable with influenza C virus. It is now known that both the receptor-binding and receptor-destroying activities, as well as the fusion activity of influenza C virus are mediated by the only glycoprotein present on the surface of the virus particle. The structure and functions of this protein, which is designated as HEF, are reviewed in this chapter.
format Online
Article
Text
id pubmed-7131673
institution National Center for Biotechnology Information
language English
publishDate 1991
publisher Academic Press Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71316732020-04-08 Structure and Function of the Hef Glycoprotein of Influenza C Virus Herrler, Georg Klenk, Hans-Dieter Adv Virus Res Article Soon after the first isolation of an influenza C virus from a patient, it became obvious that this virus differs from other myxoviruses in several aspects. Pronounced differences have been observed in the interactions between the virus and cell surfaces, suggesting that influenza C virus attaches to the receptors different from those recognized by other myxoviruses. While influenza A and B viruses agglutinate erythrocytes from many species, including humans, the spectrum of erythrocytes agglutinated by influenza C virus is much more restricted. Erythrocytes from rats, mice, and adult chickens are suitable for hemagglutination and hemadsorption tests; cells from other species, however, react not at all or only poorly with influenza C virus. Differences are also observed so far as hemagglutination inhibitors are concerned. A variety of glycoproteins have been shown to prevent influenza A and B viruses from agglutinating erythrocytes. In the case of influenza C virus, rat serum was for a long time the only known hemagglutination inhibitor. A difference in the receptors for influenza C virus and other myxo-viruses was also suggested by studies on the receptor-destroying enzyme. The ability of influenza C virus to inactivate its own receptors was reported soon after the first isolation of this virus from a patient. However, the influenza C enzyme did not affect the receptors of other myxoviruses and, conversely, the receptor-destroying enzyme of either of the latter viruses was unable to inactivate the receptors for influenza C virus on erythrocytes. While the enzyme of influenza A and B virus was characterized as a neuraminidase in the 1950s, even with refined methodology no such activity was detectable with influenza C virus. It is now known that both the receptor-binding and receptor-destroying activities, as well as the fusion activity of influenza C virus are mediated by the only glycoprotein present on the surface of the virus particle. The structure and functions of this protein, which is designated as HEF, are reviewed in this chapter. Academic Press Inc. Published by Elsevier Inc. 1991 2008-03-01 /pmc/articles/PMC7131673/ /pubmed/1957719 http://dx.doi.org/10.1016/S0065-3527(08)60280-8 Text en © 1991 Academic Press Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Herrler, Georg
Klenk, Hans-Dieter
Structure and Function of the Hef Glycoprotein of Influenza C Virus
title Structure and Function of the Hef Glycoprotein of Influenza C Virus
title_full Structure and Function of the Hef Glycoprotein of Influenza C Virus
title_fullStr Structure and Function of the Hef Glycoprotein of Influenza C Virus
title_full_unstemmed Structure and Function of the Hef Glycoprotein of Influenza C Virus
title_short Structure and Function of the Hef Glycoprotein of Influenza C Virus
title_sort structure and function of the hef glycoprotein of influenza c virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131673/
https://www.ncbi.nlm.nih.gov/pubmed/1957719
http://dx.doi.org/10.1016/S0065-3527(08)60280-8
work_keys_str_mv AT herrlergeorg structureandfunctionofthehefglycoproteinofinfluenzacvirus
AT klenkhansdieter structureandfunctionofthehefglycoproteinofinfluenzacvirus